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Investigation of the relationship between sleep duration, all-cause
mortality, and preexisting disease
Abstract

Objective: To examine the relationship between sleep duration and mortality and to quantify the likely
impact of residual confounding due to poor health status on any observed association. Methods: The sample
included 227,815 Australian adults aged 45 years and older recruited from 2006– 2009 (the 45 and Up
Study). Sleep duration and relevant covariates (e.g., health status, demographic factors) were assessed through
a self-report questionnaire. These data were linked with mortality data from the New South Wales Registry of
Births, Deaths, and Marriages up to December 2010 (mean follow-up period, 2.8 y). Cox proportional hazards
models examined the relationship between sleep duration and all-cause mortality adjusting for relevant
sociodemographic covariates (e.g., age, gender, marital status), with further stratification by baseline health
status based on physical functioning and preexisting disease. Results: The adjusted mortality risk was
significantly higher in individuals reporting(hazard ratio [HR], 1.13[1.01–1.25]) and ≥10 hours of sleep
(HR, 1.26[1.16–1.36]), compared to those reporting 7 hours of sleep per night. These associations differed by
baseline health status (p[interaction] = 0.026) such that there was no significant relationship of sleep duration
to mortality in those with good health at baseline. Conclusion: Following careful prospective controlling for
baseline health, mortality risk does not significantly vary according to sleep duration. Previous findings
suggesting a relationship between sleep duration and mortality could be affected by residual confounding by
poor preexisting health, as reflected by a combination of preexisting illnesses and functional limitations.
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ABSTRACT

Objective: To examine the relationship between sleep duration and mortality and to quantify
the likely impact of residual confounding due to poor health status on any observed
association.
Methods: The sample included 227,815 Australian adults aged 45 years and older recruited
from 2006–2009 (the 45 and Up Study). Sleep duration and relevant covariates (e.g., health
status, demographic factors) were assessed through a self-report questionnaire. These data
were linked with mortality data from the New South Wales Registry of Births, Deaths, and
Marriages up to December 2010 (mean follow-up period, 2.8 y). Cox proportional hazards
models examined the relationship between sleep duration and all-cause mortality adjusting
for relevant sociodemographic covariates (e.g., age, gender, marital status), with further
stratification by baseline health status based on physical functioning and preexisting disease.
Results: The adjusted mortality risk was significantly higher in individuals reporting
<6 hours of sleep (hazard ratio [HR], 1.13[1.01–1.25]) and ≥ 10 hours of sleep (HR,
1.26[1.16–1.36]), compared to those reporting 7 hours of sleep per night. These associations
differed by baseline health status (p[interaction] = 0.026) such that there was no significant
relationship of sleep duration to mortality in those with good health at baseline.
Conclusion: Following careful prospective controlling for baseline health, mortality risk
does not significantly vary according to sleep duration. Previous findings suggesting a
relationship between sleep duration and mortality could be affected by residual confounding
by poor preexisting health, as reflected by a combination of preexisting illnesses and
functional limitations.
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INTRODUCTION

A growing body of research indicates a U-shaped association between sleep duration
and mortality risk. In particular large-scale epidemiological studies indicate that individuals
who report short (e.g., ≤ 6 hours a night) and long sleep (e.g., ≥ 9 hours a night) durations
have elevated odds of mortality relative to those sleeping 7 – 8 hours a night [1-12]. A
number of mechanisms have been proposed to explain this relationship. For instance, it has
been suggested that short sleep could contribute to mortality via chronic health conditions
(e.g., heart disease and diabetes) and/or by increasing the likelihood of accidents because of
impaired cognitive functioning.
Despite causal mechanisms that have been proposed linking long sleep to mortality, a
number of studies have suggested that this association likely reflects residual confounding
with underlying poor health [13], and the relationship of short sleep to mortality may be
similarly affected. However, detailed empirical data on this are limited. Hence, rather than
sleep duration independently contributing to mortality risk, it is possible that individuals with
preexisting health conditions experience disturbed sleep patterns with these preexisting
conditions themselves contributing to greater mortality [1] and [14]. Preexisting health
conditions have been shown to underlie the relationships between sleep disturbances and
other health outcomes. For instance, Cairns et al. [15] found that the apparent association
between daytime napping and subsequent cancer risk was the result of underlying disease,
rather than napping itself contributing to cancer risk.
Few studies have examined the impact of preexisting health conditions on the association
between sleep and mortality, and those that are available have produced mixed results. Patel
et al. [7], Suzuki et al. [10], and Kakizaki et al. [16] found that short sleep was linked with
5

elevated mortality in both healthy and less healthy individuals. In contrast, using a wider
variety of health-related measures, Mesas et al. [1] only observed the association between
short sleep and mortality in those with poorer cognitive function. The findings for long sleep
have been more consistent, with long sleep generally associated with mortality risk regardless
of health status [1], [7], [8], [10] and [16]. However, Kakizaki et al. [16] did find that the
relationship between long sleep and stroke mortality was higher in those with poorer health,
as reflected by self-rated health and physical function.
In our paper, we aimed to prospectively investigate the relationship between sleep duration
and mortality. This investigation involved examining the extent to which any observed
variation in these relationships could be explained by baseline health status. We assessed
health status in relation to preexisting health conditions (e.g., cancer, heart disease) and
physical functional limitation; in combination, these factors provide a more comprehensive
measure of baseline health compared to some previous studies, and they allow for an
examination of the severity of poor health. We hypothesized, a priori, that if sleep duration
were to independently and causally influence mortality as suggested by previous research,
then an association between sleep duration and mortality would be evident in individuals who
were healthy and less healthy at baseline, provided appropriate statistical power is present. If
this association is absent in individuals in adequate health at baseline and is only present in
individuals with preexisting disease or functional limitation, this finding would suggest that
that there is residual confounding with poor baseline health in the association between sleep
duration and mortality risk.
METHODS
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Our paper utilized data collected through the 45 and Up Study, a large cohort study of
267,153 adults ages 45 years and older who resided in the state of New South Wales in
Australia. The primary objective of the 45 and Up Study is to collect information from a large
heterogeneous sample of adults to investigate healthy aging [17]. Participants for this study
were recruited through the Medicare Australia enrollment database, which is the publicly
funded health insurance system in Australia and includes virtually all Australian residents.
Potential participants were mailed a self-report questionnaire assessing a variety of
sociodemographic and health-related factors; the response rate was approximately 18%.
Informed consent was obtained from all participants and the 45 and Up Study received ethics
approval from the University of New South Wales Human Research Ethics Committee.
Ethics approval to use the 45 and Up Study data in our paper was obtained from the New
South Wales Population and Health Services Ethics Committee.
Measures
Data on all variables assessed in this study besides the index of remoteness and
mortality were derived the baseline 45 and Up Study questionnaire. The self-report
questionnaire asked the following question on sleep duration, “About how many hours in
each 24-hour day do you usually spend sleeping (including at night and naps)?” Sleep
duration was reported on a continuous scale and then divided into 6 categories: < 6 hours
sleep, 6 hours sleep (i.e., ≥ 6 hours and < 7 hours), 7 hours (i .e., ≥ 7 hours and < 8 hours), 8
hours (i.e., ≥ 8 hours and < 9 hours), 9 hours (i.e., ≥ 9 hours and < 10 hours), and ≥ 10 hours
[9]. The reference category was defined, a priori, as 7 hours in a 24-hour period, which is
consistent with previous research [9]. Data on all-cause mortality between February 1, 2006
and December 31, 2010 were available from the New South Wales Registry of Births, Deaths
and Marriages and were linked through the Centre for Health Record Linkage (CHeReL:
NSW, Australia). The mean period of follow-up was 2.8 years.
7

Health status was determined on the basis of preexisting illness at baseline and
functional capacity. The presence of preexisting illness was based on self-reported doctor
diagnosis of diabetes mellitus, heart disease, or stroke, as well as melanoma, breast cancer (in
women), prostate cancer (in men), and other cancers. These conditions were chosen to be as
consistent as possible with the Charlson comorbidity index scale [18] using the available
data. There were complete data for all comorbid preexisting illnesses (e.g., diabetes mellitus,
heart disease, stroke, melanoma, breast cancer [in women], prostate cancer [in men], other
cancers), but we excluded a small number of individuals who had undergone treatment for
cancer in the month prior to the survey (n = 6708).
Functional capacity was assessed using the 10-item physical functioning subscale of
the Medical Outcomes Study; this subscale is equivalent to the physical functioning subscale
of the short-form health survey 36 [19]. Higher scores on this scale indicate fewer functional
limitations. On the basis of preexisting illness and functional capacity we created 2 groups:
(1) healthy, whereby individuals had no reported disease at baseline and a physical
functioning score of 75 to 100 and (2) less healthy, defined as having one or more chronic
conditions at baseline or a physical functioning score of less than 75. There were some
missing data on responses to the physical functioning items; for participants with less than
50% of missing data on these items, imputation based on the mean of other values was used
[20]. However, when more than 50% of items were missing, the Medical Outcomes Study
physical functioning scale variable was treated as missing (N = 21,364); for these individuals
health status was assigned by preexisting serious illness. We note that this did not bias the
reported results, as a sensitivity analysis that excluded these 21,364 individuals produced
highly concordant results as those reported with unchanged conclusions.
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A number of covariates were included in the analyses. These included gender, age
(divided into 5-year age groups), education level (no school certificate or other qualification,
school

of

intermediate

certificate,

higher

school

or

leaving

certificate,

trade/diploma/certificate, and University degree or higher), and marital status (single,
widowed, divorced or separated, married or de facto relationship). In addition, participants
were asked about their health insurance status (no private health insurance, private health
insurance, or Department of Veterans’ Affairs card), and their yearly household income (in
Australian dollars) before tax (< $10 000, $10 000-$29 999, $30 000-$69 999, > $70 000,
with “I would rather not answer the question” as a further response category). Information on
weekly alcohol consumption (0 drinks, 1 – 7 drinks, 8 – 14 drinks, ≥ 15 drinks), physical
activity (≤ 30 min/d, > 30 min/d), and smoking status (current smoker, former smoker, never
smoker) were also collected, as were self-reported height and weight which were used to
calculate body mass index (≤18.5 kg/m 2, 18.5 -<25.0 kg/m2, 25.0-29.9 kg/m2, ≥30.0 kg/m2).
Participant postcodes derived from the Medicare Australia enrollment database were
used to assess remoteness (i.e., if individuals lived in a major city, rural, or remote area). This
process was achieved using the Accessibility/Remoteness Index of Australia (ARIA) [21], in
which participants were categorized as living in a major city (ARIA, 0–0.2), an inner regional
area (ARIA > 0.2 and
≤ 2.4), an outer regional area (ARIA > 2.4 and ≤ 5.92), or a
remote/very remote area (ARIA > 5.92). Participants with missing data for sleep duration,
age, or gender (n=7426) were excluded from the analyses. For the remaining variables, an
additional category was created to code missing data where appropriate.
Statistical Analysis
The association between sleep duration and all-cause mortality was examined using
Cox proportional hazards models, with time to death from date of baseline questionnaire
9

specified as the outcome. Individuals surviving the follow-up period were treated as censored
observations. All models satisfied the Cox proportional hazards model assumption. The
analyses were performed using Stata version 11.1, with the relative risk for death estimated
for each sleep category relative to the reference category expressed as a hazard ratio (HR),
with 95% confidence intervals (CI). The analyses involved testing an initial model, in which
we examined the relationship between sleep duration and mortality, controlling for age and
gender. A second model was then tested whereby we entered additional covariates into the
analysis. For parsimony, covariates that did not explain variation in all-cause mortality at
p < 0.05 were removed from the final multivariate model.
We examined the main association between sleep duration and mortality separately for
individuals defined as healthy and less healthy. An interaction term examining if the
relationship between sleep duration and mortality varied according to health status was then
added to the model. This interaction term was formed as a multiplicative combination of the
categorical sleep duration predictor with 6 categories (one of which [7 h] was the reference
category) and the binary health status covariate with 2 categories (one of which [healthy] was
the reference category). The significance of the interaction term was examined using a
likelihood ratio test, which compared the model with and without the interaction terms.
Investigation of a significant interaction effect was separately performed for the healthy and
less healthy groups. Statistical significance was determined by a p value of <0.05.

RESULTS
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Linked data were available for 241,949 adults; however, the final sample consisted of
227,815 participants (53.7% women, 46.3% men) aged 45 years and older at baseline when
cases with missing data (e.g., sleep duration, age, gender) were excluded. Most participants
were aged 45 to 64 years at baseline (60.7%). Consistent with cohorts from other countries,
the majority of our sample reported sleep durations of 7 hours (23.9%) or 8 hours (40.7%) a
night. As shown in Table 1, 15.8% reported short sleep (i.e., ≤6 hours a night) with 19.6%
reporting long sleep duration (i.e.,≥9 hours). Females and individuals aged ≥80 years were
significantly more likely to report short sleep, whereas long sleep was more likely to be
reported by males and those aged≥80 years.

Baseline health status was also significantly

associated with sleep duration. In particular, there was evidence of a U-shaped association
between pre-existing illness and sleep duration, as well as between physical functioning and
sleep duration.

Table 1. The relationship between sleep duration and key study variables.
<6 h
(n = 8308;
3.6%)

6h
(n = 27,797;
12.2%)

7h
(n = 54,336;
23.9%)

8h
(n = 97,791;
40.7%)

9h
(n = 27,111;
11.9%)

P 10 h
(n = 17,472;
7.7%)

Gender

p Value
<0.001

Women

4905 (4.0%)

15,223
(12.5%)

28,626
(23.4%)

50,821
(41.6%)

14,392
(11.8%)

8170 (6.7%)

Men

3403 (3.2%)

12,574
(11.9%)

25,710
(24.3%)

41,970
(39.7%)

12,719
(12.0%)

9302 (8.8%)

Age

<0.001
17,852
(12.8%)

37,936
(27.2%)

58,751
(42.1%)

13,943
(10.0%)

12,863
(19.7%)

26,182
(40.1%)

9639 (14.8%) 6637 (10.2%)

45–64 y

4426 (3.2%)

6650 (4.8%)

65–79 y

2538 (3.9%) 7359 (11.3%)

P 80 y

1344 (5.8%) 2586 (11.2%) 3537 (15.4%) 7858 (34.1%) 3529 (15.3%) 4185 (18.2%)

Preexisting
illnesses
21,460
(12.2%)

None

5855 (3.3%)

P1

2453 (4.7%) 6337 (12.0%)

44,188
(25.2%)

72,945
(41.6%)

19,952
(11.4%)

10,148
(19.3%)

19,846
(37.7%)

7159 (13.6%) 6666 (12.7%)

10,806 (6.2%) <0.001

MOS-PF
<75

<0.001
2873 (6.4%) 5832 (13.0%) 7371 (16.4%)

15,117
(33.7%)

6144 (13.7%) 7570 (16.9%)
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<6 h
(n = 8308;
3.6%)
75–100

5435 (3.0%)

6h
(n = 27,797;
12.2%)
21,965
(12.0%)

7h
(n = 54,336;
23.9%)
46,965
(25.7%)

8h
(n = 97,791;
40.7%)
77,674
(42.5%)

9h
(n = 27,111;
11.9%)
20,967
(11.5%)

P 10 h
(n = 17,472;
7.7%)

p Value

9902 (5.4%)

Abbreviations: h, hour; y, year; MOS-PF, Medical Outcomes Study-Physical
Functioning Scale.

Over the 5-year period, there was a total of 8782 deaths from all causes. After
adjusting for age and gender, the risk for mortality during the follow-up period was
significantly higher in individuals reporting short or long sleep duration compared to those
reporting 7 hours of sleep per night (Table 2; hazard ratios [HRs]) (95% CI, 1.27[1.14–1.41]
for ≤6 hours and 1.43[1.32-1.54] for ≥10 hours ). These associations were attenuated with
additional adjustment for age, gender, marital status, private health insurance, smoking status,
alcohol consumption, body mass index, physical activity, and baseline health status.
However, in the total sample short sleep (HR, 1.13[1.01–1.25]) and long sleep duration (HR,
1.26[1.16–1.36]) remained significantly associated with mortality risk compared to 7 hours of
sleep.

Table 2. The relationship between sleep duration and mortality risk in the total sample. Data
are presented as hazard ratios (with 95% confidence intervals) adjusted for covariates.
Adjusted for age and gender
N

IY

Events
HR

<6 h

8308

6h
7h

Fully adjusted resultsa

23,616 429

95% CI

HR

95% CI

1.27*

1.14–1.41

1.13*

1.01–1.25

27,796 78,756 1016

1.03

0.96–1.11

0.99

0.91–1.06

54,335 153,205 1803

Referent

Referent
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Fully adjusted resultsa

Adjusted for age and gender
N

IY

Events
HR

95% CI

HR

95% CI

8h

92,789 258,233 3302

1.03

0.97–1.09

1.02

0.96–1.08

9h

27,111 74,394 1088

1.05

0.97–1.13

1.04

0.96–1.12

P10 h

17,471 47,184 1144

1.43*

1.32–1.54

1.26*

1.16–1.36

Abbreviations: CI, confidence interval; h, hour; HR, hazard ratio; IY, individual-years; N, number of
participants.
* p < 0.05.
a

HR adjusted for age, gender, marital status, private health insurance, smoking status, alcohol

consumption, body mass index, sufficient physical activity, and baseline health status.

When these relationships were separately examined in those classified as healthy at baseline,
the association was attenuated such that there was no significant relationship of sleep
duration to mortality (corresponding HRs, 1.09[0.89–1.32] and 1.03[0.88–1.20], respectively)
(Fig. 1; Table 3). In contrast, a U-shaped relationship between sleep duration and mortality
was observed in the less healthy group. The sleep duration by health status interaction was
significant (for interaction, 12.69; p = 0.026), indicating that the relationship between sleep
duration and mortality varied by baseline health status.
Figure 1. Mortality risk associated with each of the sleep categories for individuals in the
healthy (A) and less healthy groups (B). Data are presented as hazard ratios (with 95%
confidence intervals) adjusted for covariates. Although the hazard curves are separately
shown in the figure, they were estimated from a single model based on the main effects for and an interaction term between - health status and sleep duration.
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DISCUSSION
In the present sample, and without comprehensive consideration of baseline health
status, both short (< 6 hours) and long ( ≥ 10 hours) sleep were significantly associated with
all-cause mortality, independent of a range of sociodemographic and behavioral factors. This
finding is consistent with existing studies conducted in countries such as the United States,
the United Kingdom, Finland, and Singapore [7], [8], [11] and [12]. However, further
investigation indicated that the nature of this association significantly varied based on health
status, which was assessed in relation to preexisting illness (e.g., cancer, heart disease) and
functional limitation (determined using the Medical Outcomes Study Physical Functioning
scale). In particular we found that short and long sleep duration were not associated with
elevated mortality when data were restricted to individuals who were healthy at baseline. This
group is least likely to have findings affected by residual confounding or reverse causality.

Table 3. Hazard ratios showing the association of sleep duration with mortality risk from a
model including an interaction term between sleep duration and health status.
N

IY

Events

HR

95% CI

Healthy group a
<6 h

3252

9315

113

1.09

0.89–1.32
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N

IY

Events

HR

95% CI

6h

15,585 44,521 432

0.92

0.83–1.04

7h

35,884 101,451 1018

Referent –

8h

56,951 158,751 1564

0.97

0.89–1.05

9h

14,597 40,040 408

0.94

0.83–1.05

P 10 h

5724

15,506 201

1.03

0.88–1.20

14,301 316

1.20*

1.05–1.38
0.96–1.19

Less healthy groupb
<6 h

5056

6h

12,211 34,230 584

1.07

7h

18,451 51,751 785

Referent

8h

35,839 99,478 1738

1.10*

1.01–1.20

9h

12,514 34,354 680

1.14*

1.03–1.27

P 10 h

11,747 31,675 943

1.38*

1.25–1.52

Abbreviations: CI, confidence interval; h, hour; HR, hazard ratio; IY, individual-years; N,
number of participants.
* p < 0.05.
a

Group characterized by absence of cancer, heart disease, diabetes mellitus, and stroke, and
method of scoring physical functioning (MOS-PF) score ⩾75.

b

Group characterized by the presence of one or more chronic conditions at baseline and a MOS-PF

<75.

This finding is important, as a variety of mechanisms have been proposed to explain
the relationship between sleep duration and mortality. It has been suggested, for example, that
shorter sleep durations contribute to elevated mortality risk via pathways such as an increased
risk for chronic health conditions including heart disease, diabetes mellitus, and obesity,
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which have been linked with shorter sleep durations and overall mortality. Grandner and
Drummond [13] also proposed that factors such as changes in cytokine levels and a reduced
photoperiod (i.e., the rate of daylight to darkness) may contribute to elevated mortality in
long sleepers.
Our results provide some evidence against these causal mechanisms and suggest that
the relationship between sleep duration and mortality is due to residual confounding with
poor health at baseline. This conclusion is based on the proposition that if sleep duration were
genuinely causally related to mortality, then an association would be observed regardless of
health status. Using data on the presence of specific chronic health conditions and functional
limitations due to poor physical health or disability we were able to, a priori, define a group
that was less likely to have substantial variations in sleep durations due to preexisting poor
health. Because we did not observe an association between sleep duration and mortality in
this specific group despite reasonable power, it suggests that residual confounding may
underlie the relationship between sleep duration and mortality observed in the total sample.
Our findings are novel, as few studies have previously investigated if the association
between sleep duration and mortality varies according to health status. Available studies
indicate that short and long sleep generally are associated with mortality risk regardless of
health status [1], [7], [8] and [10]. The exception has been shown in the study by Mesas et al.
[1], who observed that the relationship between short sleep duration and mortality was only
evident in individuals with poorer cognitive functioning. However, research investigating the
relationship between insomnia and mortality risk also has indicated that this association is
only evident in those with preexisting health conditions [22]. It is important to note that the
assessment of health status has been relatively limited in previous studies examining sleep
duration and mortality, with the focus primarily on preexisting disease. This is a limitation, as
it is likely that sleep duration varies not only according to whether or not someone has a
16

specific illness (e.g., ischemic heart disease) but also according to the severity of the disease.
This information is not appropriately captured by adjustment for binary variables reflecting
health status (e.g., presence vs absence of a health condition). As a result, residual
confounding may not have been effectively addressed in previous studies. Our research is
better able to address this, as we assessed health status in relation to preexisting illness and
functional limitations, which are more indicative of an individual’s overall health. Therefore,
our results provided supportive evidence that the nature of the association varies by health
status and that residual confounding may well account for previous associations between
sleep duration and mortality.
It is important to acknowledge that there are several ways to assess residual
confounding. In addition to the approach adopted in our paper, another method involves
investigating if the relationship between sleep duration and mortality changes with increasing
duration of follow-up. If, for example, the magnitude of the relationship diminishes over
time, then it suggests that the association is due to residual confounding with another factor at
baseline. We were unable to perform these analyses in our study given that our analyses were
limited to a relatively short period of follow-up. However, Cairns et al. [15] recently adopted
this approach to investigate the relationship between daytime napping and the risk for cancer.
Their results demonstrated that the magnitude of this relationship significantly weakened
over time such that daytime napping was not associated with breast cancer and only
marginally associated with other cancers 4 or more years after baseline. This finding suggests
that the relationship between daytime napping and cancer risk also could be from preexisting
disease. Therefore, although residual confounding can be difficult to investigate, it is
something that needs to be carefully examined in the context of sleep duration and outcomes
such as mortality. Two possible ways of investigating residual confounding in the present
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context are to investigate the effects of preexisting health concerns and the effects of
increased duration of follow-up.
Despite the novelty of the findings, there are several limitations of our study. Many
large cohort studies use a single item to asses sleep duration, but this is potentially
problematic as it may lead to inaccurate estimates of sleep duration and be biased by factors
such as age. For example, self-reported sleep duration moderately correlates with actigraphmeasured sleep but may overestimate sleep duration by up to 52 minutes a night [23].
Although this is a limitation of this study, the overestimation of sleep duration may bias the
results towards the null. This hypothesis is supported by research showing that the magnitude
of the U-shaped association between sleep duration and mortality is less pronounced when
using subjective vs objective measures of sleep duration [23].
A further consideration is that sleep duration is just one dimension of sleep and does
not provide an indication of sleep disturbances, which also may be important in
understanding how sleep is related to mortality [24]. Future research should therefore assess
other dimensions of sleep, such as sleep quality and sleep disturbances in addition to sleep
duration. Our study included a range of factors that could potentially confound the
association between sleep duration and mortality in addition to preexisting health. However,
other factors such as obstructive sleep apnea and depression may also confound these
relationships but were not included in our paper. Therefore, it is possible that the associations
observed in the less healthy groups are the result of residual confounding due to these other
factors. Future research may benefit from addressing these other variables as potential
confounders to further clarify the nature of the relationship between sleep duration and
mortality.
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The period of follow-up in our study was relatively short, which can be a concern, as
sleep is estimated to be relatively close to the event and also because the potential effects of
sleep on mortality may take a longer period of time to occur. As noted above, longer periods
of follow-up also could be beneficial in further investigating residual confounding.
A final limitation of our study relates to the response rate of 18%. Although this
response rate is consistent with many contemporary cohort studies, it does raise the
possibility of biases due to a lack of representativeness. In general, the 45 and Up Study is
underrepresented by men, younger individuals, and those living in major cities [25]. In
addition, the sample is wealthier and healthier (reflected by lower smoking rates and higher
self-rated health) compared to the general population [25]. Empirical data from the 45 and Up
Study support the general epidemiologic axiom that relative risks based on internal
comparisons within the cohort are unlikely to be biased by lack of representativeness;
however, the possibility of bias cannot be entirely excluded [25] and [26].
Conclusions
Despite these limitations, our study also has a lot of strengths including the use of
longitudinal data from a large sample size. In addition, we were able to control for a large number of
covariates (e.g., sociodemographic factors, health behaviors), which could have confounded the
relationship between sleep duration and mortality. The utilization of a multidimensional measure to
assess health, which combined preexisting health conditions with functional limitations to assess
health status, also is a key strength of our study. This is because the combined measure incorporated
both the presence and severity of a preexisting illness or health condition, and hence enabled us to
better examine if residual confounding explained the relationship between sleep duration and
mortality. This component is important, as sleep duration is increasingly discussed as a potential risk
factor for mortality, but our results indicate that the nature of the relationship varies according to
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health status and is not evident in individuals without health concerns and functional limitations at
baseline. In combination with the known relationships of sleep disturbance to baseline health, the
null findings of the sleep duration mortality in healthier individuals in our study suggest that the
observed relationship of short and long sleep duration to mortality may well be a result of the
preexisting disease.

ACKNOWLEDGEMENTS
This research was completed using data collected through the 45 and Up Study
(www.45andUp.org.au). The 45 and Up Study is managed by the Sax Institute in
collaboration with major partner Cancer Council New South Wales; and partners the Heart
Foundation (NSW Division); NSW Ministry of Health; beyondblue: the national depression
initiative; Ageing, Disability and Home Care, NSW Family and Community Services;
Australian Red Cross Blood Service; and UnitingCare Ageing. This project was supported by
a development grant from the National Heart Foundation, NSW Cardiovascular Research
Network made available through the 45 and Up Cardiovascular Research Collaboration.
Professor Banks is supported by the Australian National Medical Research Council. We
thank the many thousands of people participating in the 45 and Up Study

20

REFERENCES
1.

Mesas AE, López-García E, León-Muñoz LM, Guallar-Castillón P, Rodríguez-Artalejo
F. Sleep duration and mortality according to health status in older adults. J Am Geriatr
Soc 2010;58:1870-7.

2.

Amagai Y, Ishikawa S, Gotoh T, et al. Sleep Duration and Mortality in Japan: the Jichi
Medical School Cohort Study. J Epidemiol 2004;14:124-28.

3.

Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. Sleep duration and mortality: the
effect of short or long sleep duration on cardiovascular and all-cause mortality in
working men and women. Sleep Med 2003;3:305-14.

4.

Hublin C, Partinen M, Koskenvuo M, Kaprio J. Sleep and Mortality: A PopulationBased 22-Year Follow-Up Study. Sleep 2007;30:1245-53.

5.

Ikehara S, Iso H, Date C, et al. Association of Sleep Duration with Mortality from
Cardiovascular Disease and Other Causes for Japanese Men and Women: the JACC
Study. Sleep 2009;32:259 - 301.

6.

Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated
with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.

7.

Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and
mortality risk in women. Sleep 2004;27:440-4.

8.

Shankar A, Koh W-P, Yuan J-M, Lee H-P, Yu MC. Sleep duration and coronary heart
disease mortality among Chinese adults in Singapore: A population-based cohort study.
Am J Epidemiol 2008;168:1367-73.

21

9.

Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep Duration and All-Cause
Mortality: A Systematic Review and Meta-Analysis of Prospective Studies. Sleep
2010;33:585-92.

10.

Suzuki E, Yorifuji T, Ueshima K, et al. Sleep duration, sleep quality and cardiovascular
disease mortality among the elderly: a population-based cohort study. Prev Med
2009;2-3:135-41.

11.

Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep
duration: Associations with mortality in the Whitehall II Cohort. Sleep 2007;30:165966.

12.

Kronholm E, Laatikainen T, Peltonen M, Sippola R, Partonen T. Self-reported sleep
duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep
Med 2011;12:215-21.

13.

Grandner M, Drummond SP. Who are the long sleepers? Towards an understanding of
the mortality relationship. Sleep Med Rev 2007;11:341-60.

14.

Grandner M, Hale L, Moore M, Patel NP. Mortality associated with short sleep
duration: the evidence, the possible mechanisms, and the future. Sleep Med Rev
2010;14:191-203.

15.

Cairns BJ, Travis RC, Wang X-S, Reeves GK, Green J, Beral V. A short-term increase
in cancer risk associated with daytime napping is likely to reflect pre-clinical disease:
prospective cohort study. Br J Cancer 2012;107:527-30.

16.

Kakizaki M, Kuriyama S, Nakaya N, Sone T, Nagai M, Sugawara Y, et al. Long sleep
duration and cause-specific mortality according to physical function and self-rated
health: The Ohsaki Cohort Study. J Sleep Res in press.
22

17.

Banks E, Jorm L, Lujic S, Rogers K. Health, ageing and private health insurance:
baseline results from the 45 and Up Study cohort. Aust N Z Health Policy 2009;6:17.

18.

Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation. J Chronic
Dis 1987;40:373-83.

19.

Ware JE, Kosinski M, Gandek B. SF-36 Health Survey Manual & Interpretation Guide.
Lincoln: RI: QualityMetric Incorporated; 1993, 2000.

20.

Hayes RD, Sherbourne CD, Mazel RM. RAND: User’s manual for the Medical
Outcomes Study (MOS) core measures of Health-Related Quality of Life.

Santa

Monica: CA: RAND; 1995.
21.

Australian Bureau of Statistics. Australian Standard Geographical Classification
(ASGC) July 2008. Canberra: Australian Bureau of Statistics; 2008.

22.

Hublin C, Partinen M, Koskenvou M, Kaprio J. Heritability and mortality risk of
insomnia-related symptoms: A genetic epidemiologic study in a population-based twin
cohort. Sleep 2011;34: 957 – 64.

23.

Kripke DF, Langer RD, Elliot JA, Klauber MR, Rex KM. Mortality related to
actigraphic long and short sleep. Sleep Med 2011;12:28-33.

24.

Chandola T, Ferrie JE, Perski A, Akbaraly TN, Marmot MG. The effect of short sleep
duration on coronary heart disease risk is greatest among those with sleep disturbance:
a prospective study from the Whitehall II cohort. Sleep 2010;33:739-44.

23

25.

Mealing NM, Banks E, Jorm LR, Steel DF, Clements MS, Rogers KD. Investigation of
relative risk estimates from studies of the sample population with contrasting response
rates and designs. BMC Med Res Methodol 2010;10:26.

26.

Ponsonby, A-L, Dwyer T, Couper D. Is this finding relevant? Generalisation and
epidemiology. Aust N Z J Public Health 1996; 20: 54 – 56.

24

